Third Harmonic Bio Files 2025 Proxy Statement
| Field | Detail |
|---|---|
| Company | Third Harmonic Bio, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: THRD
TL;DR
THRD proxy filed, shareholders vote on directors 6/5. Governance details inside.
AI Summary
Third Harmonic Bio, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 5, 2025. The filing covers the fiscal year ending December 31, 2024, and includes information on director nominations and other corporate matters. Key individuals mentioned in relation to board roles include Christopher Murphy and Natalie Holles, both designated as Members.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, director elections, and proposals to be voted on at the upcoming annual meeting, impacting their voting rights and the company's future direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not contain new financial or operational risks.
Key Numbers
- 20250605 — Annual Meeting Date (Date for shareholder voting)
- 2024-12-31 — Fiscal Year End (Reporting period covered)
Key Players & Entities
- Third Harmonic Bio, Inc. (company) — Registrant
- Christopher Murphy (person) — Board Member
- Natalie Holles (person) — Board Member
- 0000950170-25-058305 (filing_id) — Accession Number
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information for the upcoming annual meeting, including details on director nominations and other corporate governance matters.
When is the shareholder meeting scheduled?
The shareholder meeting is scheduled for June 5, 2025.
Who are some key individuals mentioned in the filing regarding board roles?
Christopher Murphy and Natalie Holles are mentioned as Members, likely in relation to board positions.
What is the fiscal year end for Third Harmonic Bio, Inc. that this filing pertains to?
The filing pertains to the fiscal year ending December 31, 2024.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 25, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 by Christopher Murphy regarding Third Harmonic Bio, Inc..